12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome

International Journal of Cardiology

Volumn 146, Issue 1, 2011, Pages 68-72

  Yun, Kyeong Ho ^a   Oh, Seok Kyu ^a   Rhee, Sang Jae ^a   Yoo, Nam Jin ^a   Kim, Nam Ho ^a   Jeong, Jin Won ^a  

^a Wonkwang University Hospital   (South Korea)

Author keywords

Acute coronary syndrome; Angioplasty; Complications; Statins; Stents

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; CHOLESTEROL; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; ROSUVASTATIN; TRIACYLGLYCEROL; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; STROKE; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; FLUOROBENZENES; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PYRIMIDINES; SULFONAMIDES; TREATMENT OUTCOME;

EID: 78650801255     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.04.052     Document Type: Article

References (18)

1. G. Patti, V. Pasceri, and G. Colonna Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial J Am Coll Cardiol 49 2007 1272 1278
2. G.G. Schwartz, A.G. Olsson, and M.D. Ezekowitz Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial JAMA 285 2001 1711 1718
3. K.K. Ray, C.P. Cannon, and C.H. McCabe Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial J Am Coll Cardiol 46 2005 1405 1410
4. K.H. Yun, M.H. Jeong, and S.K. Oh The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome Int J Cardiol 137 2009 246 251
5. V. Pasceri, G. Patti, A. Nusca, C. Pristipino, and G. Richichi Di Sciascio G; ARMYDA investigators. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of Myocardial Damage during Angioplasty) study Circulation 110 2004 674 678
6. K.A. Fox, P.A. Poole-Wilson, and R.A. Henderson Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina Lancet 360 2002 743 751
7. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Eur Heart J 28 2007 2525 2538 (Pubitemid 47616190)
8. C. Briguori, A. Colombo, and F. Airoldi Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction Eur Heart J 25 2004 1822 1828
9. R. Ebrahimi, J. Saleh, and E. Toggart Effect of preprocedural statin use on procedural myocardial infarction and major cardiac adverse events in percutaneous coronary intervention: a meta-analysis J Invasive Cardiol 20 2008 292 295
10. M. Takemoto, and J.K. Liao Pleiotropic effects of 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitors Arterioscler Thromb Vasc Biol 21 2001 1712 1719
11. A.C. Sposito, and M.J. Chapman Statin therapy in acute coronary syndromes. Mechanistic insight into clinical benefit Arterioscler Thromb Vasc Biol 22 2002 1524 1534
12. M. Nishino, S. Hoshida, and H. Kato Preprocedural statin administration can reduce thrombotic reaction after stent implantation Circ J 72 2008 232 237
13. K.H. Yun, I.S. Shin, and E.M. Park Effect of additional statin therapy on endothelial function and prognosis in patients with vasospastic angina Korean Circ J 38 2008 638 643
14. O. Gach, V. Legrand, Y. Biessaux, J.P. Chapelle, S. Vanbelle, and L.A. Pierard Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris Am J Cardiol 99 2007 31 35
15. A. Gaspardone, F. Crea, and F. Versaci Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina Am J Cardiol 82 1998 515 518
16. N. Saleh, B. Svane, and L. Hansson Response of serum C-reactive protein to percutaneous coronary intervention has prognostic value Clin Chem 51 2005 2124 2130
17. T. Nakachi, M. Kosuge, and K. Hibi C-reactive protein elevation and rapid angiographic progression of nonculprit lesion in patients with non-ST-segment elevation acute coronary syndrome Circ J 72 2008 1953 1959
18. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150